{"id":"NCT03404401","sponsor":"Braintree Laboratories","briefTitle":"A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy","officialTitle":"BLI4700-301: A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-11","primaryCompletion":"2018-07-10","completion":"2018-07-10","firstPosted":"2018-01-19","resultsPosted":"2021-09-08","lastUpdate":"2021-09-08"},"enrollment":620,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Colonoscopy"],"interventions":[{"type":"DRUG","name":"BLI4700","otherNames":[]},{"type":"DRUG","name":"Polyethylene glycol bowel preparation","otherNames":[]}],"arms":[{"label":"BLI4700 Bowel Preparation","type":"EXPERIMENTAL"},{"label":"FDA Approved Bowel Preparation","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this study is to compare the safety and efficacy of BLI4700 bowel preparation to an FDA-approved bowel preparation as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.","primaryOutcome":{"measure":"Number and Percentage of Subjects With Successful Bowel Cleansing","timeFrame":"Day of colonoscopy","effectByArm":[{"arm":"BLI4700 Bowel Preparation","deltaMin":257,"sd":null},{"arm":"FDA Approved Bowel Preparation","deltaMin":241,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":21},"locations":{"siteCount":23,"countries":["United States"]},"refs":{"pmids":["33165006"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":281},"commonTop":["dizziness"]}}